Marjolein De Bruijn

Marjolein de Bruijn


+31 20 512 2067 Daniela Thommen

I joined Daniela Thommen when she started her own research group within the NKI in April 2020.

Currently, I am working on translational research questions by using our ex vivo human cancer model to assess the effects of immunotherapies on different types of human cancers.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.